UCB (UCB)

Index:

BEL 20

  260.55
   
  • Change Today:
     6.35
  • 52 Week High:  261.40
  • 52 Week Low:  129.35
  • Currency: Euro
  • Shares Issued: 190.00m
  • Volume: 18,697
  • Market Cap:  49,505m
  • Beta: 1.86

UCB Overview

UCB is a Belgian manufacturer of biopharmaceutical products. The company is engaged in the provision of therapy for central nervous system disorders, inflammatory and oncology disorders. UCB head office is located in Brussels.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.5%
Div Cover 4.0
Op Mrgn 23.6%
ROCE 33.1%
Latest F'cast
P/E 45.3
PEG 0.2
Pr/Revenue 8.6
Pr/Book 4.8
Latest F'cast
Revenue 15.3%
PBT 163.7%
EPS 209.9%
DPS 2.2%

UCB Fundamentals

Year Ending Revenue ( m) Pre-tax ( m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 5,052.00 880.00 387.00¢ 21.8 n/a -8% 127.00¢ 1.5%
31-Dec-21 5,777.00 1,226.00 560.00¢ 17.9 0.4 +45% 130.00¢ 1.3%
31-Dec-22 5,517.00 511.00 221.00¢ 33.3 n/a -60% 133.00¢ 1.8%
31-Dec-23 4,867.00 441.00 181.00¢ 43.6 n/a -18% 136.00¢ 1.7%
31-Dec-24 5,613.00 1,163.00 561.00¢ 34.3 0.2 +210% 139.00¢ 0.7%

UCB ShareCast News

Belgium's UCB to buy US-based Ra Pharmaceuticals... 10-Oct-2019 ShareCast

UCB Top Newspaper Links

GSK gets emerging markets boost with UCB deal 24-Jan-2009 Telegraph
UCB confident on drug go-ahead 21-Aug-2007 The Scotsman
Fellner shuffles Acambis board 08-Mar-2007 Telegraph

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Forecast figures based on normalised accounts.

 

UCB Market Data

Currency Euro
Share Price   260.55
Change Today   6.35
% Change 2.50 %
52 Week High  261.40
52 Week Low  129.35
Volume 18,697
Shares Issued 190.00m
Market Cap  49,505m
Beta 1.86

Trades for 14-Jan-2026

Time Volume / Share Price
10:23 1 @  260.60
10:23 7 @  260.60
10:23 13 @  260.60
10:21 12 @  260.80
10:20 20 @  260.70

Top of Page